Pharmaceuticals, Biotechnology and Life Sciences
Dicerna Pharmaceuticals Board of Directors approved the grant of inducement stockoptions to purchase a total of 145,500 shares of common stock to bedistributed among eight new employees
Approval based on data showing Kadcyla cut the risk of diseaserecurring by half compared to Herceptin in the adjuvant setting forspecific patients with HER2-positive early breast cancer
Health Canada hasapproved the supplemental New Drug Submission that expands the use ofADCETRIS (brentuximab vedotin) in combination with AVD (Adriamycin,vinblastine and dacarbazine) chemotherapy in patients with previouslyuntreated Stage IV Hodgkin lymphoma (HL).
DUBLIN–(BUSINESS WIRE)–The “Stability Testing of Pharmaceuticals” conference has been added to ResearchAndMarkets.com’s offering. Design efficient stability studies that are suitable…
DUBLIN–(BUSINESS WIRE)–The “Decision Making and Problem Solving in the Pharma Industry” conference has been added to ResearchAndMarkets.com’s offering. A two-day…
DUBLIN–(BUSINESS WIRE)–The “How to Write Effective SOPs” conference has been added to ResearchAndMarkets.com’s offering. An essential course for ensuring compliance…
DUBLIN–(BUSINESS WIRE)–The “Stability Testing of Pharmaceuticals” conference has been added to ResearchAndMarkets.com’s offering. By attending this comprehensive two-day seminar delegates…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global laryngeal cancer therapeutics market is expected to post a CAGR of over 7% during the…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global cancer biologics market is expected to post a CAGR of over 11% during the period…
DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance – Understanding PhV Today” conference has been added to ResearchAndMarkets.com’s offering. This course aims to provide basic…